Jakafi

(ruxolitinib)
NO BOXED WARNING

Dosage & Administration

Doses should be individualized based on safety and efficacy. Starting doses per indication are noted below.

Myelofibrosis

Polycythemia Vera


Acute Graft-Versus-Host Disease


Chronic Graft-Versus-Host Disease


Get Your Patient on Jakafi

See your patient's specific prior authorization requirements including coverage restrictions and step therapies
Or select your Insurance from the list below:

Jakafi Prescribing Information

Jakafi Prior Authorization Resources

Most recent Jakafi prior authorization forms

Most recent state uniform prior authorization forms

Jakafi PubMed™ News

5 most recent articles for Jakafi, view all articles on PubMed™
Show the latest PubMed™ articles for Jakafi